| 2025 JNPMEDI Partners Demo Day held on the 4th at Sheraton Grand Incheon Hotel in Songdo
| Startups, alongside domestic and international investors, gather to share growth achievements and explore follow-on investment opportunities
| Judges from Murex Partners and SoluM, along with industry experts, provide strategic insights through live Q&A
| IR presentations by innovative companies including EzDiatech, BioSolvix, ReadyCure, MEDI-IoT, and Healing Sound
JNPMEDI Partners, an accelerator specializing in pharmaceutical, biotech, and medical device startups, successfully concluded the 2025 JNPMEDI Partners Demo Day on the 4th at the Sheraton Grand Incheon Hotel in Songdo. The event was designed to provide startups with a platform to showcase their growth and connect directly with investors.
The JNPMEDI Partners Demo Day was held as part of the Investment Attraction Support Program Linked to Specialized Investment Institutions, led by the Korea Health Industry Development Institute (KHIDI). The program aims to help participating companies secure meaningful investment networking opportunities and potential follow-on funding to support global expansion. JNPMEDI Partners offered hands-on support throughout the process, including pitch training, IR deck refinement, one-on-one investor matching, and coordination of follow-up meetings to accelerate startup growth.
The judging panel included key figures from Murex Partners and SoluM, as well as SooHyun Lew, Chief Medical Officer, JNPMEDI, and JaeHyun Lee, Chief of Staff, JNPMEDI Partners. The judges evaluated each company’s IR presentation and provided strategic, practical feedback.
Five companies participated in the Demo Day: EzDiatech, BioSolvix, ReadyCure, MEDI-IoT, and Healing Sound. Each company delivered a 15-minute presentation followed by a 5-minute Q&A session, introducing their innovative technologies, business models, and growth strategies. Active discussions followed, with judges and investors offering insights grounded in real-world investment and commercialization experience.
The event concluded with an open networking session, allowing deeper conversations between startups and investors. Participants described the Demo Day as “a meaningful opportunity to assess real performance and growth potential,” expressing optimism that it would lead to concrete follow-on investment opportunities.
JaeHyun Lee, Chief of Staff, JNPMEDI Partners, commented, “This Demo Day went beyond a simple pitching event. It served as a practical platform where startups and investors in the pharmaceutical, biotech, and medical device sectors could build trust and meaningful connections. We will continue to contribute to the growth of Korea’s biohealth industry by discovering promising companies and supporting strong investment partnerships.”
| 2025 JNPMEDI Partners Demo Day held on the 4th at Sheraton Grand Incheon Hotel in Songdo
| Startups, alongside domestic and international investors, gather to share growth achievements and explore follow-on investment opportunities
| Judges from Murex Partners and SoluM, along with industry experts, provide strategic insights through live Q&A
| IR presentations by innovative companies including EzDiatech, BioSolvix, ReadyCure, MEDI-IoT, and Healing Sound
JNPMEDI Partners, an accelerator specializing in pharmaceutical, biotech, and medical device startups, successfully concluded the 2025 JNPMEDI Partners Demo Day on the 4th at the Sheraton Grand Incheon Hotel in Songdo. The event was designed to provide startups with a platform to showcase their growth and connect directly with investors.
The JNPMEDI Partners Demo Day was held as part of the Investment Attraction Support Program Linked to Specialized Investment Institutions, led by the Korea Health Industry Development Institute (KHIDI). The program aims to help participating companies secure meaningful investment networking opportunities and potential follow-on funding to support global expansion. JNPMEDI Partners offered hands-on support throughout the process, including pitch training, IR deck refinement, one-on-one investor matching, and coordination of follow-up meetings to accelerate startup growth.
The judging panel included key figures from Murex Partners and SoluM, as well as SooHyun Lew, Chief Medical Officer, JNPMEDI, and JaeHyun Lee, Chief of Staff, JNPMEDI Partners. The judges evaluated each company’s IR presentation and provided strategic, practical feedback.
Five companies participated in the Demo Day: EzDiatech, BioSolvix, ReadyCure, MEDI-IoT, and Healing Sound. Each company delivered a 15-minute presentation followed by a 5-minute Q&A session, introducing their innovative technologies, business models, and growth strategies. Active discussions followed, with judges and investors offering insights grounded in real-world investment and commercialization experience.
The event concluded with an open networking session, allowing deeper conversations between startups and investors. Participants described the Demo Day as “a meaningful opportunity to assess real performance and growth potential,” expressing optimism that it would lead to concrete follow-on investment opportunities.
JaeHyun Lee, Chief of Staff, JNPMEDI Partners, commented, “This Demo Day went beyond a simple pitching event. It served as a practical platform where startups and investors in the pharmaceutical, biotech, and medical device sectors could build trust and meaningful connections. We will continue to contribute to the growth of Korea’s biohealth industry by discovering promising companies and supporting strong investment partnerships.”